Prelude Capital Management, LLC Biolife Solutions Inc Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $3,893 - $5,203	-248 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$15.2 - $19.42 $69,676 - $89,021	-4,584 Reduced 94.87%	248 $4,000
Q1 2019 May 15, 2019	BUY	$10.9 - $21.26 $42,956 - $83,785	3,941 Added 442.31%	4,832 $86,000
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $6,631 - $11,984	698 Added 361.66%	891 $11,000
Q3 2018 Nov 14, 2018	BUY	$14.99 - $25.48 $2,893 - $4,917	193 New	193 $3,000

169

46.4M

11.6K

800

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.1B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.